PE20070809A1 - VETERINARY COMPOSITION INCLUDING CLOSANTEL - Google Patents

VETERINARY COMPOSITION INCLUDING CLOSANTEL

Info

Publication number
PE20070809A1
PE20070809A1 PE2006001584A PE2006001584A PE20070809A1 PE 20070809 A1 PE20070809 A1 PE 20070809A1 PE 2006001584 A PE2006001584 A PE 2006001584A PE 2006001584 A PE2006001584 A PE 2006001584A PE 20070809 A1 PE20070809 A1 PE 20070809A1
Authority
PE
Peru
Prior art keywords
composition
composition including
closantel
veterinary composition
agent
Prior art date
Application number
PE2006001584A
Other languages
Spanish (es)
Inventor
Alistair Couper
Mona Ferry
Lillian Cromie
Willy Blakely
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of PE20070809A1 publication Critical patent/PE20070809A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: A) UNA SALICILANILIDA TAL COMO CLOSANTEL QUE SE ENCUENTRA EN UNA CANTIDAD DE 1% A 30% P/V DE LA COMPOSICION; B) UN AGENTE ANTIPARASITICIDA TAL COMO BENCENOSULFONAMIDA O BENCIMIDAZOL; C) UN AGENTE DE AMPLIO ESPECTRO TAL COMO IVERMECTINA. DICHA COMPOSICION INHIBE LA CAPACIDAD REPRODUCTIVA DE ENDOPARASITOS EN DESARROLLO Y LA FORMA MADURA DE DICHOS PARASITOS TAL COMO FASCIOLA HEPATICA, HAEMONCHUS CONTORTUS, OESTRUS OVIS, ENTRE OTROS, SIENDO DE USO VETERINARIOIT REFERS TO A COMPOSITION THAT INCLUDES: A) A SALICILANILIDE SUCH AS CLOSANTEL WHICH IS IN AN AMOUNT OF 1% TO 30% W / V OF THE COMPOSITION; B) AN ANTIPARASITICIDAL AGENT SUCH AS BENZENOSULFONAMIDE OR BENZYMIDAZOLE; C) AN AGENT OF WIDE SPECTRUM SUCH AS IVERMECTIN. SUCH COMPOSITION INHIBITS THE REPRODUCTIVE CAPACITY OF DEVELOPING ENDOPARASITES AND THE MATURE FORM OF SUCH PARASITES SUCH AS FASCIOLA HEPATICA, HAEMONCHUS CONTORTUS, OESTRUS OVIS, AMONG OTHERS, BEING OF VETERINARY USE

PE2006001584A 2005-12-09 2006-12-11 VETERINARY COMPOSITION INCLUDING CLOSANTEL PE20070809A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0525093.1A GB0525093D0 (en) 2005-12-09 2005-12-09 Veterinary composition

Publications (1)

Publication Number Publication Date
PE20070809A1 true PE20070809A1 (en) 2007-08-27

Family

ID=35735821

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001584A PE20070809A1 (en) 2005-12-09 2006-12-11 VETERINARY COMPOSITION INCLUDING CLOSANTEL

Country Status (4)

Country Link
AR (1) AR058298A1 (en)
GB (2) GB0525093D0 (en)
PE (1) PE20070809A1 (en)
WO (1) WO2007066130A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2991173B1 (en) 2012-06-04 2015-11-06 Virbac VETERINARY COMPOSITION WITH OXYCLOZANIDE BASED SKIN ADMINISTRATION
EA022327B1 (en) * 2013-01-04 2015-12-30 Общество С Ограниченной Ответственностью "Рубикон" Injection veterinary preparation as a solution for combating animal polyinvasions and method for production thereof
EP3338783B1 (en) 2014-09-12 2024-01-24 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
EP3403652A1 (en) 2017-05-18 2018-11-21 Veterinärmedizinische Universität Wien Prevention and treatment of fibroblast growth factor 23 (fgf23)-associated disorders including chronic kidney disease (ckd)
IT201800004309A1 (en) * 2018-04-09 2019-10-09 Topical treatments for ocular myiasis
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028887A1 (en) * 1993-06-15 1994-12-22 The Australian National University Synergistic anthelmintic compositions
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Also Published As

Publication number Publication date
AR058298A1 (en) 2008-01-30
WO2007066130A2 (en) 2007-06-14
GB0624565D0 (en) 2007-01-17
WO2007066130A3 (en) 2007-08-16
GB0525093D0 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
PE20070809A1 (en) VETERINARY COMPOSITION INCLUDING CLOSANTEL
GT200200114A (en) SHAMPOOS WITH BEHENYL ALCOHOL
ECSP045407A (en) BENZAZOLES SUBSTITUTED AND THE USE OF THE SAME AS INHIBITORS OF QUINASA RAF
AR059456A1 (en) BENEFICIAL AGENT UNDERSTANDING SUPPLY PARTICLES
GT200300002A (en) COMPOSITIONS OF GUM AND CHEESE CONFITERIA WITH COMPOSITIONS OF AGENT THAT ELIMINAMANCHASENCAPSULADO AND PROCEDURES FOR HIS MANUFACTURE AND USE
ECSP077299A (en) NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORO-3-TRIFLUOROMETIL-FENIL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
NI200800060A (en) BENCIMIDAZOLS REPLACED AS CINASA INHIBITORS.
PE20030802A1 (en) IMMEDIATE RELEASE DOSAGE FORMS CONTAINING SOLID DRUG DISPERSIONS
CL2010000234A1 (en) Fungicidal combination comprising fluoxaestrobin and at least one imidazole selected from cyzofamid, prochloraz, triazoxide or pefurazoate and uses thereof to combat phytopathogenic fungi and in obtaining fungicidal compositions that also comprise spreading agents and / or surfactants (divisional of 2673-2005 )
CR9626A (en) DOSAGE WAYS OF ORAL DELAYED ORAL DELIVERY RELEASE OF AN O-DESMETILVENLAFAXIN SUCCINATE
CR7107A (en) EMPLOYMENT OF FATTY ALCOHOL ETOXYLATES AS FAVORENTS OF PENETRATION
AR040205A1 (en) HERBICIDE COMPOSITION
PA8654201A1 (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TAXANS MODIFIED IN C-2
CR7678A (en) HETEROCICLILPYRIMIDINOS REPLACED
GT200000141A (en) EXTRUIBLE CEMENTOUS MATERIAL.
BRPI0608287A2 (en) endoparasiticidal agent
HN2001000225A (en) DENTAL WHITENING COMPOSITION AND PROCEDURE USED BY A DICARBOXILIC ACID WHITENING AGENT
ECSP099611A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCILITICAL AGENT
AR083329A1 (en) COMPOSITIONS FOR ORAL CARE
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
AR029092A1 (en) COMPOSITIONS FOR HAIR TREATMENT
CO2023018652A2 (en) Fluorinated tryptamine compounds, analogues of these and methods of use of these
DOP2006000030A (en) NEW SALT FORM OF A DOPAMINE AGONIST
CR7515A (en) VETERINARY COMPOSITION INJECTABLE FOR SMALL ANIMALS
AR050276A1 (en) COMPOSITIONS FOR PERSONAL HYGIENE SUBSTANTIALLY FREE OF ENZYMES THAT UNDERSTAND NON-SILICATES WITH CATIONIC LOAD IN THE BASE LAYER

Legal Events

Date Code Title Description
FA Abandonment or withdrawal